Literature DB >> 11240308

Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders.

M K Osterlund1, Y L Hurd.   

Abstract

The steroid hormone estrogen influences brain function and neuropsychiatric disorders, but neuroanatomical information about the estrogen receptors (ERs) are rather limited. The main focus of this article is to provide an overview of the current status of the ER distribution and possible function in the human brain. The ERs are ligand activated transcription factors that belong to the steroid hormone receptors, included in the nuclear receptor superfamily. To date, there are two known ER subtypes, alpha and beta. In the human forebrain, both estrogen receptor subtypes are predominantly expressed in limbic-related areas, although they show distinct distribution patterns. The ERalpha mRNA expression appears to dominate in the hypothalamus and amygdala, indicating that the alpha-subtype might modulate neuronal cell populations involved in autonomic and reproductive neuroendocrine functions as well as emotional interpretation and processing. In contrast, the hippocampal formation, entorhinal cortex, and thalamus appear to be ERbeta dominant areas, suggesting a putative role for ERbeta in cognition, non-emotional memory and motor functions. Clinical observations of estrogenic effects together with the information available today regarding ER expression in the primate brain provide important clues as to the functional aspects of the two ER subtypes. However, further characterization of the different phenotypes of the ER expressing cells in the human brain is needed as well as the delineation of the genes which are regulated by the ERs and how this transcriptional control correlates with human behavior and mental status.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240308     DOI: 10.1016/s0301-0082(00)00059-9

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  56 in total

1.  Postmenopausal hormone use impact on emotion processing circuitry.

Authors:  Tal Shafir; Tiffany Love; Alison Berent-Spillson; Carol C Persad; Heng Wang; Nancy K Reame; Kirk A Frey; Jon-Kar Zubieta; Yolanda R Smith
Journal:  Behav Brain Res       Date:  2011-09-14       Impact factor: 3.332

Review 2.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 3.  A review of estrogen receptor alpha gene (ESR1) polymorphisms, mood, and cognition.

Authors:  Erin E Sundermann; Pauline M Maki; Jeffrey R Bishop
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 4.  Rapid signaling mechanisms of estrogens in the developing cerebellum.

Authors:  Scott M Belcher
Journal:  Brain Res Rev       Date:  2007-09-14

5.  Effects of the gender factor and neonatal androgenization on the dendroarchitectonics of neurons in the dorsomedial nucleus of the amygdaloid body of the brain.

Authors:  A V Akhmadeev
Journal:  Neurosci Behav Physiol       Date:  2007-06

Review 6.  Estrogen and leptin regulation of endocrinological features of anorexia nervosa.

Authors:  Lynda M Brown; Deborah J Clegg
Journal:  Neuropsychopharmacology       Date:  2013-01       Impact factor: 7.853

7.  Hormonal environment affects cognition independent of age during the menopause transition.

Authors:  Alison Berent-Spillson; Carol C Persad; Tiffany Love; MaryFran Sowers; John F Randolph; Jon-Kar Zubieta; Yolanda R Smith
Journal:  J Clin Endocrinol Metab       Date:  2012-06-22       Impact factor: 5.958

Review 8.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

Review 9.  Polymorphisms of estrogen receptors and risk of depression: therapeutic implications.

Authors:  Joanne Ryan; Marie-Laure Ancelin
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

10.  Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Authors:  J A Cobb; K O'Neill; J Milner; G J Mahajan; T J Lawrence; W L May; J Miguel-Hidalgo; G Rajkowska; C A Stockmeier
Journal:  Neuroscience       Date:  2015-12-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.